Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterNo recent work listed

Xiao Ling Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2485-9445; OpenAlex author ID A5033450333. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2014: 4 papers · 2015: 2 papers · 2016: 2 papers · 2017: none · 2018: 1 paper

Papers 9

  1. Precision design of nanomedicines to restore gemcitabine chemosensitivity for personalized pancreatic ductal adenocarcinoma treatment. Co-author DOI 10.1016/j.biomaterials.2017.12.015↗
  2. Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy. Co-author DOI 10.1016/j.biomaterials.2016.06.032↗
  3. An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Efficacy in Pancreatic Cancer. Co-author DOI 10.1021/acsami.5b11619↗
  4. Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2014.12.028↗
  5. SCF, regulated by HIF-1α, promotes pancreatic ductal adenocarcinoma cell progression. Co-author DOI 10.1371/journal.pone.0121338↗
  6. The clinical significance and regulation mechanism of hypoxia-inducible factor-1 and miR-191 expression in pancreatic cancer. Co-author DOI 10.1007/s13277-014-2452-5↗
  7. Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin. Co-author DOI 10.1158/0008-5472.can-13-3009↗
  8. CypA, a gene downstream of HIF-1α, promotes the development of PDAC. Co-author DOI 10.1371/journal.pone.0092824↗
  9. [Effects of dioscin on apoptosis in pancreatic cancer MiaPaCa-2 cells and its mechanism]. Co-author PMID 24685079↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jihui Hao · 9 shared papers, 2014–2018 · strength 0.46
  2. He Ren · 5 shared papers, 2014–2018 · strength 0.26
  3. Guangjun Nie · 4 shared papers, 2015–2018 · strength 0.22
  4. Xiuchao Wang · 4 shared papers, 2014–2018 · strength 0.20
  5. Song Gao · 4 shared papers, 2014 · strength 0.20
  6. Ruifang Zhao · 3 shared papers, 2016–2018 · strength 0.17
  7. He Ren · 3 shared papers, 2014 · strength 0.15
  8. Yiye Li · 2 shared papers, 2015–2016 · strength 0.11
  9. Tianjiao Ji · 2 shared papers, 2016 · strength 0.10
  10. Jing Chen · 2 shared papers, 2015 · strength 0.10
  11. Chuntao Gao · 2 shared papers, 2014–2015 · strength 0.08
  12. Tiansuo Zhao · 2 shared papers, 2014–2015 · strength 0.08
  13. Yongwei Wang · 1 shared paper, 2018 · strength 0.07
  14. Hai Wang · 1 shared paper, 2015 · strength 0.05
  15. Zhenguo Song · 1 shared paper, 2014 · strength 0.05
  16. Shengyu Yang · 1 shared paper, 2014 · strength 0.04
  17. Mingxiao Lang · 1 shared paper, 2015 · strength 0.04
  18. Huan Zhang · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.